Press Releases
12 February 2020
RESEARCH TRIANGLE PARK, N.C., Feb. 12, 2020 /PRNewswire/ -- T3D Therapeutics, Inc. ("T3D" ), a clinical stage drug development company engaged in the development of T3D-959, a new orally administered treatment for Alzheimer's disease (AD), announced today the formation of a new Scientific Advisory Board in concert with the initiation of the PIONEER Phase 2 clinical
Read more...12 February 2020
CHICAGO, Feb. 12, 2020 /PRNewswire/ -- CareLight Solutions is proud to now be offering a complete line of industry-leading Light Therapy products to the public. Inspired by Nobel Prize-winning science, Light Therapy devices are backed by years of scientific research and are FDA-cleared to reduce pain and increase circulation. Based in
Read more...- Over 26 million Americans with a behavioral health issue go untreated.[i] - Investment will enable next-level growth of pioneering immersive therapy for depression, anxiety and other behavioral health conditions.- Largest investment funding for VR therapy in the UK and Europe.[ii] OXFORD, England, Feb. 12, 2020 /PRNewswire/ -- VR therapy pioneer
Read more...12 February 2020
STOCKHOLM, Feb. 12, 2020 /PRNewswire/ -- "2019 was the year when Alligator entered the clinical phase on a broad front. At the beginning of the year, we had one clinical project and at year-end, the number had increased to four", commented CEO Per Norlén.Significant events October - December - The first patient was dosed in a Phase I study w
Read more...12 February 2020
WEST PALM BEACH, Florida, Feb. 12, 2020 /PRNewswire/ -- The possibility of a global pandemic virus spreading out of control is indeed terrifying. There is a very specific feeling of helplessness that accompanies fighting an enemy that is invisible, relentless and able to move among us silently, without remorse or hesitation. The
Read more...DUBLIN, Feb. 11, 2020 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company"), a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, announced today the pricing of its underwritten public offering of 5,500,000 ordinary shares at a price
Read more...11 February 2020
CHICAGO, Feb. 11, 2020 /PRNewswire/ -- John R. Agar, DDS, MA, FACP, was honored with the Major General Bill B. Lefler Federal Services Award by the American College of Prosthodontists (ACP). Dr. Agar received this award at the 49th Annual Session of the ACP in Miami, Oct. 3
Read more...11 February 2020
CHICAGO, Feb. 11, 2020 /PRNewswire/ -- David L. Pfeifer, DDS, MS, MEd, FACP, was recently honored with the American College of Prosthodontists Education Foundation (ACPEF) Founders Society Award. This award recognizes an individual who has made a significant impact on the growth and development of the Foundation and has demonstrated an ext
Read more...11 February 2020
ORANGE COUNTY, Calif., Feb. 11, 2020 /PRNewswire/ -- Gregory L. Bentley, co-founder of Bentley & More LLP, and his client Hilary Corts were interviewed by the Today Show to highlight Hilary's ongoing legal battle with Allergan over the company's defective and recalled BIOCELL textured breast implants.
Read more...11 February 2020
SAN DIEGO, Feb. 11, 2020 /PRNewswire/ -- Decipher Biosciences, a commercial-stage precision oncology company committed to improving patient care, initially focused on urologic cancers, today announced the appointments of Robert S. Epstein, M.D., and Kathy Hibbs, Esq. to its Board of Directors. Dr. Epstein was also elected Ch
Read more...
